Logo Logo
Hilfe
Hilfe
Switch Language to English

Sirtl, Simon; Beyer, Georg und Mayerle, Julia (2022): Clinical and translational markers of severity and prognosis in chronic pancreatitis. In: Current Opinion in Gastroenterology, Bd. 38, Nr. 5: S. 501-508

Volltext auf 'Open Access LMU' nicht verfügbar.

Abstract

Purpose of review The incidence of chronic pancreatitis as a progressive inflammation and fibrosis syndrome is on the rise due to increasing awareness and improved imaging modalities. Numerous classification systems have been suggested in recent years to describe the disease, but only few of them have been used to classify the severity and prognostic significance of the disease. Biomarkers for severity and (early) chronic pancreatitis diagnosis are not yet ready for clinical application. Recent findings In using the M-ANNHEIM and Chronic Pancreatitis Prognosis Score (COPPS) classification system, the severity assessment and short- and medium-term disease progression is available. A prospectively validated biomarker for early chronic pancreatitis diagnosis is not yet available, metabolome-based approaches seem to have the greatest potential for clinical translation. Summary Currently, due to the lack of universal definition for the early disease stage of chronic pancreatitis, it is difficult to accurately classify these patient cohorts in existing scoring systems. In principle, setting up a suitable scoring system would allow surveillance and establish a therapy approaches flanked by corresponding biomarker panel development. Therapy management of chronic pancreatitis and monitoring by means of scoring systems (such as the COPPS) would make a decisive contribution to improving patient treatment.

Dokument bearbeiten Dokument bearbeiten